Last deal

$72M

Amount

Series C

Stage

26.06.2023

Date

3

all rounds

$102M

Total amount

General

About Company
Presidio Medical develops a neuromodulation platform to treat chronic pain.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Presidio

founded date

2017

Number of employees

Last funding type

Series C

IPO status

Private

Description

Founded in 2017 and based in South San Francisco, California, Presidio Medical is a clinical-stage medical device company focused on developing a bioelectronic medicine platform. Their goal is to establish a new class of therapeutic medical devices using biotechnology tools. By leveraging their neuromodulation platform, they aim to provide effective treatment options for diseases characterized by undesired neural activity.
Contacts